Li Watsek
Stock Analyst at Cantor Fitzgerald
(0.16)
# 4,688
Out of 5,078 analysts
124
Total ratings
37.3%
Success rate
-11.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Li Watsek
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZLAB Zai Lab | Maintained: Buy | $37 | $24.03 | +53.97% | 10 | Oct 26, 2026 | |
| CELC Celcuity | Initiated Coverage: Buy | $140 | $65.25 | +114.56% | 1 | Oct 22, 2026 | |
| ASND Ascendis Pharma | Reiterated: Buy | $300 | $243.37 | +23.27% | 27 | Sep 25, 2026 | |
| NUVB Nuvation Bio | Initiated Coverage: Buy | $12 | $4.57 | +162.58% | 1 | Aug 21, 2026 | |
| REPL Replimune Group | Upgraded: Buy | n/a | $11.46 | - | 6 | Jul 31, 2026 | |
| ANL Adlai Nortye Group | Reiterated: Buy | n/a | $10.58 | - | 2 | Jul 16, 2026 | |
| IMRX Immuneering | Initiated Coverage: Buy | $17 | $3.73 | +355.76% | 1 | Jul 8, 2026 | |
| FTH Faeth Therapeutics | Reiterated: Buy | n/a | $17.08 | - | 2 | Jun 3, 2026 | |
| CRIS Curis | Rated: Hold | n/a | $0.3863 | - | 4 | Mar 27, 2026 | |
| TYRA Tyra Biosciences | Reiterated: Buy | n/a | $20.45 | - | 2 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $21.00 | - | 1 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $0.761 | - | 1 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $18.54 | n/a | 6 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $0.2393 | n/a | 1 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.30 | n/a | 6 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $34.71 | n/a | 2 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.61 | n/a | 8 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $10.53 | n/a | 8 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.73 | n/a | 3 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 3 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $2.33 | n/a | 1 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.17 | n/a | 6 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.55 | n/a | 5 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $3.02 | n/a | 4 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $2.11 | n/a | 5 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $5 | $0.015 | n/a | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $71 → $38 | $1.79 | n/a | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $6 | $11.54 | n/a | 3 | Jun 28, 2022 |
Zai Lab
Oct 26, 2026
Maintained: Buy
Price Target: $37
Current: $24.03
Upside: +53.97%
Celcuity
Oct 22, 2026
Initiated Coverage: Buy
Price Target: $140
Current: $65.25
Upside: +114.56%
Ascendis Pharma
Sep 25, 2026
Reiterated: Buy
Price Target: $300
Current: $243.37
Upside: +23.27%
Nuvation Bio
Aug 21, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $4.57
Upside: +162.58%
Replimune Group
Jul 31, 2026
Upgraded: Buy
Price Target: n/a
Current: $11.46
Upside: -
Adlai Nortye Group
Jul 16, 2026
Reiterated: Buy
Price Target: n/a
Current: $10.58
Upside: -
Immuneering
Jul 8, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $3.73
Upside: +355.76%
Faeth Therapeutics
Jun 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $17.08
Upside: -
Curis
Mar 27, 2026
Rated: Hold
Price Target: n/a
Current: $0.3863
Upside: -
Tyra Biosciences
Mar 4, 2026
Reiterated: Buy
Price Target: n/a
Current: $20.45
Upside: -
Dec 22, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $21.00
Upside: -
Dec 3, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $0.761
Upside: -
Oct 8, 2025
Reiterated: Buy
Price Target: n/a
Current: $18.54
Upside: n/a
Oct 2, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $0.2393
Upside: n/a
Sep 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $7.30
Upside: n/a
Sep 9, 2025
Reiterated: Buy
Price Target: n/a
Current: $34.71
Upside: n/a
Jun 26, 2025
Reiterated: Buy
Price Target: n/a
Current: $9.61
Upside: n/a
Jun 12, 2025
Reiterated: Buy
Price Target: n/a
Current: $10.53
Upside: n/a
May 15, 2025
Reiterated: Buy
Price Target: n/a
Current: $1.73
Upside: n/a
May 14, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Mar 14, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $2.33
Upside: n/a
Jan 24, 2025
Reiterated: Buy
Price Target: n/a
Current: $1.17
Upside: n/a
Jun 3, 2024
Reiterated: Buy
Price Target: n/a
Current: $3.55
Upside: n/a
Aug 30, 2023
Reiterated: Buy
Price Target: $11
Current: $3.02
Upside: n/a
Aug 9, 2023
Reiterated: Hold
Price Target: $5
Current: $2.11
Upside: n/a
Aug 7, 2023
Reiterated: Buy
Price Target: $8 → $5
Current: $0.015
Upside: n/a
Aug 12, 2022
Reiterated: Buy
Price Target: $71 → $38
Current: $1.79
Upside: n/a
Jun 28, 2022
Reiterated: Buy
Price Target: $16 → $6
Current: $11.54
Upside: n/a